These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 21590769)

  • 1. Active site mutant dimethylarginine dimethylaminohydrolase 1 expression confers an intermediate tumour phenotype in C6 gliomas.
    Boult JK; Walker-Samuel S; Jamin Y; Leiper JM; Whitley GS; Robinson SP
    J Pathol; 2011 Nov; 225(3):344-52. PubMed ID: 21590769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dimethylarginine dimethylaminohydrolase-1 (DDAH1) is frequently upregulated in prostate cancer, and its overexpression conveys tumor growth and angiogenesis by metabolizing asymmetric dimethylarginine (ADMA).
    Reddy KRK; Dasari C; Duscharla D; Supriya B; Ram NS; Surekha MV; Kumar JM; Ummanni R
    Angiogenesis; 2018 Feb; 21(1):79-94. PubMed ID: 29150732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dimethylarginine dimethylaminohydrolase I enhances tumour growth and angiogenesis.
    Kostourou V; Robinson SP; Cartwright JE; Whitley GS
    Br J Cancer; 2002 Sep; 87(6):673-80. PubMed ID: 12237779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel Cellularly Active Inhibitor Regresses DDAH1 Induced Prostate Tumor Growth by Restraining Tumor Angiogenesis through Targeting DDAH1/ADMA/NOS Pathway.
    Kami Reddy KR; Dasari C; Vandavasi S; Natani S; Supriya B; Jadav SS; Sai Ram N; Kumar JM; Ummanni R
    ACS Comb Sci; 2019 Apr; 21(4):241-256. PubMed ID: 30673277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dimethylarginine dimethylaminohydrolase-1 is the critical enzyme for degrading the cardiovascular risk factor asymmetrical dimethylarginine.
    Hu X; Atzler D; Xu X; Zhang P; Guo H; Lu Z; Fassett J; Schwedhelm E; Böger RH; Bache RJ; Chen Y
    Arterioscler Thromb Vasc Biol; 2011 Jul; 31(7):1540-6. PubMed ID: 21493890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of the direct effects of DDAH I on tumour angiogenesis in vivo.
    Papaevangelou E; Boult JKR; Whitley GS; Robinson SP; Howe FA
    Angiogenesis; 2018 Nov; 21(4):737-749. PubMed ID: 29721731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repetitive ischemia increases myocardial dimethylarginine dimethylaminohydrolase 1 expression.
    Zhang P; Fassett JT; Zhu G; Li J; Hu X; Xu X; Chen Y; Bache RJ
    Vasc Med; 2017 Jun; 22(3):179-188. PubMed ID: 28145161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dimethylarginine dimethylaminohydrolase-2 deficiency promotes vascular regeneration and attenuates pathological angiogenesis.
    Lange C; Mowat F; Sayed H; Mehad M; Duluc L; Piper S; Luhmann U; Nandi M; Kelly P; Smith A; Ali R; Leiper J; Bainbridge J
    Exp Eye Res; 2016 Jun; 147():148-155. PubMed ID: 27181226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of overexpression of dimethylarginine dimethylaminohydrolase on tumor angiogenesis assessed by susceptibility magnetic resonance imaging.
    Kostourou V; Robinson SP; Whitley GS; Griffiths JR
    Cancer Res; 2003 Aug; 63(16):4960-6. PubMed ID: 12941821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenoviral-mediated overexpression of DDAH improves vascular tone regulation.
    Torondel B; Nandi M; Kelly P; Wojciak-Stothard B; Fleming I; Leiper J
    Vasc Med; 2010 Jun; 15(3):205-13. PubMed ID: 20219849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dimethylarginine dimethylaminohydrolase 1 modulates endothelial cell growth through nitric oxide and Akt.
    Zhang P; Hu X; Xu X; Chen Y; Bache RJ
    Arterioscler Thromb Vasc Biol; 2011 Apr; 31(4):890-7. PubMed ID: 21212404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dimethylarginine dimethylaminohydrolase-1 contributes to exercise-induced cardiac angiogenesis in mice.
    Shi X; Luo X; Xu X
    Biosci Trends; 2020 May; 14(2):115-122. PubMed ID: 32238672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced Renal Methylarginine Metabolism Protects against Progressive Kidney Damage.
    Tomlinson JA; Caplin B; Boruc O; Bruce-Cobbold C; Cutillas P; Dormann D; Faull P; Grossman RC; Khadayate S; Mas VR; Nitsch DD; Wang Z; Norman JT; Wilcox CS; Wheeler DC; Leiper J
    J Am Soc Nephrol; 2015 Dec; 26(12):3045-59. PubMed ID: 25855779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-193b regulates breast cancer cell migration and vasculogenic mimicry by targeting dimethylarginine dimethylaminohydrolase 1.
    Hulin JA; Tommasi S; Elliot D; Hu DG; Lewis BC; Mangoni AA
    Sci Rep; 2017 Oct; 7(1):13996. PubMed ID: 29070803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dimethylarginine dimethylaminohydrolase 1 regulates nerve growth factor-promoted differentiation of PC12 cells in a nitric oxide-dependent but asymmetric dimethylargenine-independent manner.
    Wang S; Hu CP; Yuan Q; Zhang WF; Zhou Z; Nie SD; Jiang JL; Li YJ
    J Neurosci Res; 2012 Jun; 90(6):1209-17. PubMed ID: 22488726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic variation in the dimethylarginine dimethylaminohydrolase 1 gene (DDAH1) is related to asymmetric dimethylarginine (ADMA) levels, but not to endothelium-dependent vasodilation.
    Lind L; Ingelsson E; Kumar J; Syvänen AC; Axelsson T; Teerlink T
    Vasc Med; 2013 Aug; 18(4):192-9. PubMed ID: 23892448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelial Dimethylarginine Dimethylaminohydrolase 1 Is an Important Regulator of Angiogenesis but Does Not Regulate Vascular Reactivity or Hemodynamic Homeostasis.
    Dowsett L; Piper S; Slaviero A; Dufton N; Wang Z; Boruc O; Delahaye M; Colman L; Kalk E; Tomlinson J; Birdsey G; Randi AM; Leiper J
    Circulation; 2015 Jun; 131(25):2217-25. PubMed ID: 25910799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiomyocyte dimethylarginine dimethylaminohydrolase-1 (DDAH1) plays an important role in attenuating ventricular hypertrophy and dysfunction.
    Xu X; Zhang P; Kwak D; Fassett J; Yue W; Atzler D; Hu X; Liu X; Wang H; Lu Z; Guo H; Schwedhelm E; Böger RH; Chen P; Chen Y
    Basic Res Cardiol; 2017 Aug; 112(5):55. PubMed ID: 28819685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of the ADMA-DDAH system in endothelial cells: a novel mechanism for the sterol response element binding proteins, SREBP1c and -2.
    Ivashchenko CY; Bradley BT; Ao Z; Leiper J; Vallance P; Johns DG
    Am J Physiol Heart Circ Physiol; 2010 Jan; 298(1):H251-8. PubMed ID: 19915177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA DANCR deficiency promotes high glucose-induced endothelial to mesenchymal transition in cardiac microvascular cells via the FoxO1/DDAH1/ADMA signaling pathway.
    Wu M; Li T; Li G; Niu B; Wu T; Yan L; Wang S; He S; Huang C; Tong W; Li N; Jiang J
    Eur J Pharmacol; 2023 Jul; 950():175732. PubMed ID: 37116560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.